• Dr Shane T. Grey, Associate Professor in Medicine UNSW, ARC Future Fellow and Honorary NHMRC Senior Research Fellow. Shane finished his PhD immunology training at Monash University 1995 and his post-doctoral training as a transplant immunologist at Harvard Medical School, USA 1995-1999. Shane later became involved in islet transplantation and type I diabetes research though the JDRF Islet Transplant Center at Harvard in the late 1990’s. In 2000 he received a JDRF Career Development Award to establish a research program aiming to understand how islet beta cells die; and in 2001 was appointed as Assistant Professor in Surgery at Harvard Medical School. In 2003 Shane received a NSW BioFirst Award and was recruited back to Australia to the Garvan Institute. In 2007, Shane was awarded as a Key Opinion Leader (KOL) in transplantation by The Transplantation Society International. In 2010 Shane received a JDRF- Macquarie Group Foundation Innovation Award for his work in T1D. In 2012 Shane was awarded “The Ian McKenzie Prize for outstanding contributions to transplantation” for his work in islet transplantation by the TSANZ. Shane is the head of a transplant immunology research team at the Garvan; a lead investigator on Australia's first clinical islet transplant program at Westmead; Program Director of a national NHMRC/JDRF research program for T1D and a founder of the Australian Islet Study Group.
Abstracts this author is presenting: